DEB-TACE+HAIC vs. HAIC for Large HCC

Clinical trial NCT05263219 · UNKNOWN

Trial details

NCT number: NCT05263219
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Unresectable Hepatocellular Carcinoma

Start date: 2022-02-10
Primary completion: 2026-02-09
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.